Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements.

PURPOSE Pathological changes of the peripheral pulmonary arteries induce pulmonary arterial hypertension (PAH). Aim of this study was to quantitatively assess the effect of PAH on pulmonary perfusion by 3D-MR-perfusion techniques and to compare findings to healthy controls. Furthermore, quantitative perfusion data were correlated with invasive pressure measurements. MATERIAL AND METHODS Five volunteers and 20 PAH patients (WHO class II or III) were examined using a 1.5T MR scanner. Measurement of pulmonary perfusion was done in an inspiratory breathhold (FLASH3D; 3.5 mm x 1.9 mm x 4mm; TA per 3D dataset 1.5s). Injection of contrast media (0.1 mmol Gd-DTPA/kg BW) and image acquisition were started simultaneously. Evaluation of 3D perfusion was done using singular value decomposition. Lung borders were outlined manually. Each lung volume was divided into three regions (anterior, middle, posterior), and the following parameters were assessed: Time-to-Peak (TTP), blood flow (PBF), blood volume (PBV), and mean transit time (MTT). In 10 patients invasive pulmonary artery pressure measurements were available and correlated to the perfusion measurements. RESULTS In both, controls and patients, an anterior-to-posterior gradient with higher PBF and PBV posterior was observed. In the posterior lung region, a significant difference (p<0.05) was found for TTP (12s versus 16s) and MTT (4s versus 6s) between volunteers and patients. PBF and PBV were lower in patients than in volunteers (i.e. dorsal regions: 124 versus 180 ml/100 ml/min and 10 versus 12 ml/100 ml), but the difference failed to be significant. The ratio of PBF and PBV between the posterior and the middle or ventral regions showed no difference between both groups. A moderate linear correlation between mean pulmonary arterial pressure (mPAP) and PBV (r=0.51) and MTT (r=0.56) was found. CONCLUSION The only measurable effect of PAH on pulmonary perfusion is a prolonging of the MTT. There is only a moderate linear correlation of invasive mPAP with PBV and MTT.

[1]  H. Kauczor,et al.  Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results , 2005, European Radiology.

[2]  Michael Bock,et al.  Partially Parallel Three‐Dimensional Magnetic Resonance Imaging for the Assessment of Lung Perfusion – Initial Results , 2003, Investigative radiology.

[3]  H. Kauczor,et al.  Assessment of pulmonary hypertension by CT and MR imaging , 2004, European Radiology.

[4]  P. Croisille,et al.  Prospective comparison of MR lung perfusion and lung scintigraphy , 1999, Journal of magnetic resonance imaging : JMRI.

[5]  M. Rubenfire,et al.  Secondary pulmonary hypertension--diagnosis and management. , 2005, European review for medical and pharmacological sciences.

[6]  Hans-Ulrich Kauczor,et al.  Effect of Inspiratory and Expiratory Breathhold on Pulmonary Perfusion: Assessment by Pulmonary Perfusion Magnetic Resonance Imaging , 2005, Investigative radiology.

[7]  H. Palevsky,et al.  Classification of Histologic Lesions in Primary Pulmonary Hypertension Group Medial lesions Intimal lesions Medial hypertrophy Increased smooth muscle , 2005 .

[8]  K. Zierler,et al.  On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.

[9]  M. Welch,et al.  Measurement of regional pulmonary blood flow with PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Chemla,et al.  Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.

[11]  R. Edelman,et al.  Demonstration of gravity‐dependent lung perfusion with contrast‐enhanced magnetic resonance imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[12]  Kenya Murase,et al.  Quantitative assessment of regional pulmonary perfusion in the entire lung using three‐dimensional ultrafast dynamic contrast‐enhanced magnetic resonance imaging: Preliminary experience in 40 subjects , 2004, Journal of magnetic resonance imaging : JMRI.

[13]  Konstantin Nikolaou,et al.  Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience. , 2005, Radiology.

[14]  A. Padhani MRI for assessing antivascular cancer treatments. , 2003, The British journal of radiology.

[15]  C. Bergin,et al.  Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. , 1997, AJR. American journal of roentgenology.

[16]  R. Günther,et al.  Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. , 2001, Chest.

[17]  R R Edelman,et al.  Quantitative assessment of pulmonary perfusion with dynamic contrast‐enhanced MRI , 1999, Magnetic resonance in medicine.

[18]  Martin Requardt,et al.  Time-Resolved Contrast-Enhanced Three-Dimensional Magnetic Resonance Angiography of the Chest: Combination of Parallel Imaging With View Sharing (TREAT) , 2005, Investigative radiology.

[19]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[20]  G. Hedenstierna Pulmonary perfusion during anesthesia and mechanical ventilation. , 2005, Minerva Anestesiologica.

[21]  C. Campañá,et al.  Pulmonary hypertension: classification and diagnostic algorithm. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

[22]  D. Gadian,et al.  Is quantification of bolus tracking MRI reliable without deconvolution? , 2002, Magnetic resonance in medicine.

[23]  D. Levin,et al.  Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. , 2005, American journal of respiratory and critical care medicine.